Intercure Ltd.

Annual Trend FY 2016 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income $44.8m ($62.0m) ($67.8m) ($35.7m)
Net Income From Continuing Operations $43.7m ($63.5m) ($72.8m) ($36.8m)
Total Adjustments to reconcile profit (loss) ($5.6m) $43.9m $34.6m $15.5m $17.5m $18.8m $53.3m
Depreciation & Amortization (CF) $828k $3.3m $7.4m $11.7m $13.2m $15.4m $17.1m
Depreciation $11.7m $13.2m $15.4m $17.1m
Depreciation Amortization Depletion $11.7m $13.2m $15.4m $17.1m
Adjustments For Deferred Tax Of Prior Periods ($12.8m)
Deferred Income Tax $93k $2.2m ($14.5m) ($7.3m)
Deferred Tax $93k $2.2m ($14.5m) ($7.3m)
Adjustments For Share-Based Payments $10.0m $6.5m $8.9m $2.6m $2.3m
Share-based payment (Note 18M) $68.0m $10.0m $6.5m $8.9m $2.6m $2.3m $2.4m
Asset Impairment Charge $0 $67.7m $0 $0
Total of changes in assets and liabilities $2.4m ($4.1m) ($1.7m) ($3.0m) ($91.2m) ($9.2m) $18.9m
Additional Financial Items
Adjustments For Current Tax Of Prior Period $7.6m $14.5m
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates $202k
General And Administrative Expense $8.6m $27.2m $36.1m $42.6m $53.7m
Goodwill $168.0m $190.1m $258.1m $284.2m $221.1m $224.6m ($5.6m)
Payments Of Lease Liabilities Classified As Financing Activities $576k $2.6m $3.9m $4.7m $5.5m
Proceeds From Borrowings Classified As Financing Activities $263.5m $62.7m $188.4m
Repayments Of Borrowings Classified As Financing Activities $3.4m $120.5m $119.9m $175.2m
Opening balance ($5.9m) ($36.0m) $7.3m $43.7m ($63.5m) ($72.8m) ($36.8m)
Loans granted (Note 12B) ($1.6m) ($7.3m) ($95.2m) ($5.2m) ($928k) ($545k)
Acquisition of Subsidiaries, net of cash acquired (Note 8) $387k ($19.1m) $1.6m $1.1m ($114k)
Deconsolidation of subsidiaries, net of cash (Note 8) $1.0m $2.4m
Repayment of loans granted $11.3m $14.0m $196k
Payments of contingent consideration ($3.5m) ($6.2m) ($4.2m)
Lease payments ($189k) ($576k) ($2.6m) ($3.9m) ($4.7m) ($5.5m) ($5.0m)
Repayment of loans from banks ($174k) ($3.4m) ($120.5m) ($119.9m) ($175.2m) ($45.3m)
Repayment of loan from related party ($143k) ($13.7m) ($3.6m) ($1.3m) ($76k)
Net Change in Cash ($1.7m) $221k ($4.5m) $7.2m $297k ($39k) ($44k)
Gain from deconsolidation of subsidiaries $4.6m ($1.3m) $3.3m
Changes in the fair value of financial assets through profit or loss, net ($21.0m) $37.2m $1.9m $172k $661k ($371k) $2.1m
Finance expenses, net $9.5m $6.8m $19.7m $20.1m $16.9m
Remeasurement of contingent consideration ($9.6m) $1.1m
Gain in respect of acquisition of a subsidiary ($58.8m) ($202k)
Total Adjustments of comprehensive income ($8.0m) $48.1m $36.3m $18.5m $108.7m $27.9m $34.4m
Change in Inventory $3.0m ($14.2m) ($15.5m) ($75.2m) $34.7m ($13.2m) $11.0m
Decrease (increase) in biological assets ($1.1m) ($2.0m) ($2.4m) ($799k) $5.5m ($4.2m) $5.0m
Increase in other payables $1.9m $4.3m $9.4m ($812k) $4.7m $3.9m $2.5m
Disposal (acquisition) of subsidiary, net of cash against share issuance (Note 8) $107.6m $6.9m $17.4m ($8.1m)
Additions to right-of-use assets $3.0m $6.7m $767k
Trade and other receivables $1.1m $1.8m $20.9m ($1.9m) ($1.9m) ($4.5m) ($3.7m)
Inventory and biological assets $7.7m $237k $22.8m ($2.6m) ($2.6m) ($1.4m) ($1.3m)
Trade and other payables ($1.7m) ($1.9m) ($51.1m) $7.9m $7.9m $4.6m $2.5m
Short term loan ($2.1m) ($1.3m) ($4.3m) $4.3m $4.3m $198k $25k
Short term loan to related parties ($716k) ($5.1m) ($2.6m) ($2.6m)
Issuance of shares ($107.6m) ($6.9m) ($17.4m) ($17.4m) $1.0m $1.3m
Non-controlling interests ($15.7m) $9.0m ($142k) ($142k) $1.9m $1.1m
Contingent consideration ($18.7m) $10.2m $10.2m $120k
Deferred consideration ($9.9m) $4.4m $4.4m
Lease liability ($2.0m) ($2.6m) ($2.6m) ($3.5m)
Financial assets measured at fair value through profit or loss ($47k) ($47k) ($202k)
Loss (gain) ($1.3m) $3.3m
Beginning Cash Position $196.2m $232.6m $101.1m $78.3m
Cash Flow From Continuing Financing Activities $120.4m ($82.9m) $26.5m ($46.7m)
Cash Flow From Continuing Investing Activities ($142.5m) $4.8m $17.7m ($2.0m)
Change In Account Payable $57.0m ($47.6m) ($8.9m) ($8.8m)
Change In Payable $56.2m ($43.0m) ($5.0m) ($6.4m)
Change In Payables And Accrued Expense $56.2m ($43.0m) ($5.0m) ($6.4m)
Change In Receivables $16.7m ($88.4m) $13.3m $9.3m
Change In Working Capital ($3.0m) ($91.2m) ($9.2m) $18.9m
Changes In Account Receivables ($18.3m) ($23.5m) $8.4m $30.8m
Changes In Cash $29.2m ($131.7m) ($22.8m) ($31.8m)
End Cash Position $232.6m $101.1m $78.3m $46.5m
Financing Cash Flow $120.4m ($82.9m) $26.5m ($46.7m)
Free Cash Flow $31.5m ($56.2m) ($71.3m) $13.3m
Gain Loss On Sale Of Business $0 $0 ($1.5m) $3.3m
Gain Loss On Sale Of PPE $0 $412k $394k $0
Interest Received CFI $0 $845k $0 $939k
Investing Cash Flow ($142.5m) $4.8m $17.7m ($2.0m)
Issuance Of Capital Stock $0 $0 $34.0m $1.5m
Net Business Purchase And Sale ($14.5m) ($4.2m) $405k $1.7m
Net PPE Purchase And Sale ($19.7m) ($2.6m) ($4.4m) ($3.5m)
Operating Gains Losses $418k $228k ($1.0m) $3.2m
Other Non Cash Items ($2.8m) $22.1m $26.2m $16.9m
Pension And Employee Benefit Expense $418k ($184k) $132k ($92k)
Proceeds From Stock Option Exercised $8.5m $0 $0
Purchase Of Business ($16.0m) ($4.2m) ($703k) ($765k)
Purchase Of PPE $14.0m ($19.7m) ($2.6m) ($4.4m) ($3.5m)
Sale Of Business $1.6m $0 $1.1m $2.4m
Sale Of PPE $0 $25k $0 $0
Stock Based Compensation $8.9m $2.6m $2.3m $2.4m
Unrealized Gain Loss On Investment Securities $172k $661k ($371k) $2.1m
Profit or Loss ($36.0m) $7.3m $43.7m ($63.5m) ($72.8m)
Total acquisition of subsidiary, net of cash ($385k) ($387k) ($19.1m) $1.6m $1.6m ($1.1m) $114k
Total disposal of subsidiary, net of cash ($2.5m) ($2.4m)
Cash flows from investing activities
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $1.8m $3.2m $6.3m ($1.9m) $25k ($3.6m) ($69k)
Purchase of property, plant and equipment ($28.1m) ($20.8m) ($14.0m) ($19.7m) $7.4m $6.0m $10.4m
Net Investment Purchase And Sale ($1.2m) $0
Purchase Of Investment ($1.2m) $0
Net Other Investing Changes ($108.3m) $10.7m $21.7m ($1.0m)
Net Cash from Investing Activities $845k $939k
Cash flows from financing activities
Proceeds from Debt Issuance $665k $75.5m $263.5m $62.7m $188.4m $10.2m
Issuance Of Debt $263.5m $62.7m $188.4m $21.1m
Long Term Debt Issuance $263.5m $62.7m $188.4m $21.1m
Net Issuance Payments Of Debt $137.7m ($62.0m) $7.7m ($29.1m)
Net Long Term Debt Issuance $137.7m ($62.0m) $7.7m ($29.1m)
Long Term Debt Payments ($125.7m) ($124.7m) ($180.7m) ($50.3m)
Repayment Of Debt ($125.7m) ($124.7m) ($180.7m) ($50.3m)
Common Stock Issuance $0 $0 $34.0m $1.5m
Net Common Stock Issuance $0 $0 $34.0m $1.5m
Cash Dividends Paid $0 $0 $0 $0
Effect Of Exchange Rate Changes $7.2m $297k ($39k) ($44k)
Increase in restricted cash ($20.0m) ($60k) ($465k) ($909k)
Decrease in restricted cash ($40k) ($20.0m) $7.4m $4.7m $9.1m $212k
Balance of cash and cash equivalents at beginning of year $27.3m $37.9m $196.2m $232.6m $101.1m $78.3m $46.5m
Change In Cash Supplemental As Reported $29.2m ($131.7m) ($22.8m) ($31.8m)
Interest Paid Classified As Financing Activities ($41k) ($93k) ($5.1m) $17.3m $20.9m $15.2m ($19.0m)
Interest Paid Classified As Operating Activities ($41k) $93k $5.1m ($17.3m) ($20.9m) ($15.2m) ($19.0m)
Income Taxes Paid Refund Classified As Operating Activities ($50k) $11.8m $8.0m $7.6m $12.9m $306k